MYDAYIS: payments to doctors
Payments that named MYDAYIS as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $78K
- Providers
- 332
- Transactions
- 473
- Average per transaction
- $165
The per-transaction average — $165 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 332 providers the average total is $236, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Shire North American Group Inc | $71,468 | 91.4% |
| Takeda Pharmaceuticals U.S.A., Inc. | $6,748 | 8.6% |